A comprehensive new review led by Mayo Clinic is helping shape how clinicians diagnose and treat meningioma, the most common primary brain tumor, with a focus on personalized, patient-centered care ...

VACCINATION RATE, THE RISK TO THE PUBLIC IS LOW. IN TONIGHT’S WOMAN’S DOCTOR, WE GET THE FACTS ON MENINGIOMA. IT’S A TUMOR INSIDE YOUR HEAD. THEY’RE USUALLY BENIGN, BUT AS OUR LACEE GRIFFITH EXPLAINS, ...

Northwestern Medicine scientists have discovered a potent immunotherapy approach for treating meningiomas, the most common type of primary brain tumor, according to a recent study published in Nature ...

Verzenio showed promising efficacy in high-grade meningiomas with CDK pathway or NF2 alterations, achieving progression-free survival at six months in 14 of 24 patients. Patients with NF2 alterations ...

The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...

The FDA approved a label change for the birth control shot depot medroxyprogesterone acetate (Depo-Provera), which now warns about the risk of meningioma, according to a letter posted on the agency ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.

This week, the FDA approved a label change on Depo Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors known as meningiomas.

1 in 4 sexually active women has used injectable birth control, administered into the muscle by a clinician, but many may be unaware of its association with meningioma, the most common brain tumor in ...

WESTWEGO, La. — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. Subscribe to ...

Meningiomas are the most common primary brain tumors, accounting for nearly one-third of all central nervous system (CNS) tumors. While most are benign and manageable, 20–30% progress to high-grade ...

Depot medroxyprogesterone acetate use was tied to higher meningioma risk in a large U.S. study. Other contraceptives, including IUDs and combined oral pills, showed no increased meningioma risk.